Hepatitis Policy Project

Working at the intersection of law and policy to set a course towards elimination of viral hepatitis in the United States

 

Hepatitis C is a contagious viral infection that causes inflammation in the liver. It is caused by the Hepatitis C virus (HCV), and can be acute or chronic.

 

Hepatitis C Statistics

In the United States, it is estimated that 3.5 million people are chronically infected with Hepatitis C.

Source: Edlin, et.al., HEPATOLOGY, November 2015

 

Of every 100 persons infected with HCV, approximately...

75–85

will go on to develop chronic infection

60–70

will go on to develop chronic liver disease

5–20

will go on to develop cirrhosis over a period of 20–30 years

1–5

will die from the consequences of chronic infection

 

Source: Centers for Disease Control and Prevention


There has been a 392% increase in Hepatitis C liver-related deaths in the U.S. between 2001-2016.

2001: 5,300 Cases - 2016: 20,800 Cases

Source: Polaris Observatory

Hepatitis C causes more deaths than all 60 CDC notifiable diseases combined

19,368 Hepatitis C Virus885 Pneumococcal Disease992 Tuberculosis5.136 Staph. Infections8,831 HIV

Source: Centers for Disease Control and Prevention

 
 
 

Hepatitis C Publications

Review and download white papers and research briefs from O'Neill Institute personnel.

Cover of: Full of Life document

New Publication

Full of Life: The Stories of People Affected by Hepatitis C. Read the article.

A new report published by the Institute's Hepatitis Policy Project tells the compelling stories of several men and women who are facing down hepatitis C, revealing the need to do more to eliminate its damaging effects.

Cover of: Monitoring the Hepatitis C Epidemic in the United States

Featured Publication

Monitoring the Hepatitis C Epidemic in the United States: What Tools Are Needed to Achieve Elimination? Read the article.

Hepatitis C is the most common cause of viral hepatitis infections in the US, and it can cause severe health complications such as liver cancer or death. It is estimated that 3.5 million Americans currently have Hepatitis C, yet there exists inadequate data monitoring or case surveillance conducted to determine the full scope of the disease in the US and to inform efforts to reduce prevalence. This brief focuses on the current state of Hepatitis C data monitoring and surveillance, and identifies new practical and achievable policies and actions to strengthen our capacity to work toward elimination.

 
 

Contact Us

O'Neill Institute for National and Global Health Law
600 New Jersey Avenue, NW
Washington, DC 20001
(202) 662-9203

Sonia Canzater, Hepatitis Policy Project Associate
sc1574@georgetown.edu

Jeffrey Crowley, Program Director
jsc26@georgetown.edu

The Hepatitis Policy Project is supported by a grant from Gilead Sciences.